SC II Acquisition Files for $150M IPO

Dow Jones
10/17
 

By Stephen Nakrosis

 

SC II Acquisition, a blank-check company affiliated with Nukkleus, filed for a $150 million initial public offering.

The company said its sponsor, SC Capital II Sponsor, is an indirect subsidiary of Nukkleus which is a financial technology company whose shares trade on the Nasdaq under the symbol NUKK.

SC II said Menachem Shalom, its chief executive and a director, has been CEO of Nukkleus since September 2024. Shalom is also CEO and a director of special purpose acquisition company Kochav Defense Acquisition, which completed its IPO in May.

Asaf Yarkoni, SC II's chief financial officer, has been CFO of Kamari Pharma since 2021, and is also CFO of Kochav Defense Acquisition.

SC II said it hasn't selected a business combination target, and may pursue an acquisition opportunity in any business, industry, sector or geographical location.

The company applied to list its units on The Nasdaq Global Market under the symbol SCIIU.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

October 16, 2025 18:14 ET (22:14 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10